Polaryx Therapeutics, Inc.

PLYX

As of the close on Sep 25, 2026

Price

$2.09

Market cap

$104M

P/E (diluted TTM)

—

The last four quarters are not all on file

EPS (TTM)

—

The last four quarters are not all on file

Dividend yield

—

Dividend records do not yet cover the latest payments

Figures shown here come from public SEC filings. Dates beside each section show the available history.

How Polaryx Therapeutics, Inc. Makes Money

No flow chart is shown because the available revenue and expense lines do not reconcile exactly. The reported financial history below remains available.

Financial Summary

Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.

Loading financial history…

SEC filings supply these figures; updates after the dates shown are not included. This page includes 2 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated May 28, 2026.

Ownership

Who holds the shares, as reported in SEC ownership filings.

Purchases & sales (open market or private)

		Security	Code		Price	Filing
2026-05-27	Yang Alex Keun Mo · Chief Executive Officer	Common Stock	P — Open market or private purchase	+88,453	4.07	SEC filing
2026-02-18	Landis G. Michael · Chief Financial Officer	Common Stock	P — Open market or private purchase	+2,867	2.79	SEC filing

Showing 2 of 2 rows

These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.